PriceTracker GLP-1
Loading the index…

Try

Loading the index…

Try

GLP-1 TV · Patient story · views checked Oct 2026

I took Mounjaro for 3 months - the results were astounding.

Patient storyFatOldClimber104,305 views17:26Feb 2025

Our summary

Gordon, who runs the FatOldClimber channel, reviews his first three months on Mounjaro. He says he had tried many diets over more than 10 years, including intermittent fasting and the carnivore diet, and lost weight each time but could not sustain it. His highest weight, during the pandemic, was 323 pounds (146 kilos). He chose Mounjaro over Ozempic because he says much of the research he read suggests it has a greater effect on weight loss, and he ordered it from a UK supplier because it is not available to him on the NHS.

One person's experience, in their words. Not medical advice.

What else the video covers

He says the effect on his thinking about food was almost immediate. After the first 2.5 mg injection he stopped thinking about snacks, and he reports that he has not snacked at all in three months apart from a few social occasions. He lost nine pounds in week one and seven in week two. Over three months he reports losing 45 pounds (20 kilos, about 15% of his body weight) and seven and a half inches (19 cm) from his waist. Side effects were limited, according to him, to a dry mouth on injection days and some constipation after a dose increase. He moved from 2.5 mg to 5 mg to 7.5 mg, and describes using an insulin pen to draw a fifth dose from each pen and planning to take a reduced dose from a higher-strength pen.

He says the biggest payoff has been in climbing: he sent his first V4 (6B) and reports less knee pain, lower blood pressure and no more ankle swelling. He plans to continue for another three months at 7.5 mg and to wean off later. He stresses that results vary and that viewers should do their own research.

Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.

Takeaways

The main points, in the order they come up. Tap a time to play from there.

  1. 0:00 Gordon says he struggled to keep weight off for over 10 years and reached 323 pounds during the pandemic before starting Mounjaro.
  2. 4:00 He says his focus on food disappeared the day after his first 2.5 mg injection, and he lost nine pounds in week one and seven in week two.
  3. 7:34 He reports only a dry mouth on injection days and some constipation after a dose increase, and he went from 2.5 mg to 5 mg to 7.5 mg.
  4. 10:40 After three months he reports a loss of 45 pounds (20 kilos, 15% of body weight) and seven and a half inches from his waist.
  5. 12:12 He says his climbing improved, including his first V4, along with less knee pain, lower blood pressure and no ankle swelling.
  6. 13:13 He plans to continue for another three months at 7.5 mg, aiming for 17 stone 3, and to wean off rather than stop suddenly.

Key moments

From the creator's own chapters. Tap one to play from there.

  1. 0:00 Introduction
  2. 0:48 Why I started taking it
  3. 2:45 What is Mounjaro?
  4. 4:31 What happened when I started?
  5. 7:49 Side Effects
  6. 9:11 5th Dose and Reduced Dosing
  7. 10:55 Results
  8. 12:17 What has this meant to me?

What the video says

As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.

Medication
Mounjaro
Doses mentioned
2.5 mg, 5 mg, 7.5 mg and 10 mg
Point in the journey
Month 3
Who is speaking
Patient

Questions this video answers

How much weight did he lose on Mounjaro in 3 months?

Gordon says he lost 45 pounds (20 kilos), which he puts at 15% of his body weight. He also reports losing seven and a half inches (19 cm) from his waist.

What side effects did he have on Mounjaro?

He says he had no major side effects. He reports a dry mouth on the day of each injection and noticeable constipation around the time he raised his dose.

What Mounjaro doses did he take in the first three months?

He says he started on the 2.5 mg starter dose, moved to 5 mg a month later, then raised to 7.5 mg a week early when hunger began to return. He plans to stay at 7.5 mg.

Why did he choose Mounjaro over Ozempic?

He says that from a GLP-1 point of view the two are similar, but much of the research he found suggests Mounjaro has a greater effect on weight loss, which was his goal.

Videos on the same question

The closest videos in the library by what is said in them, not by title.

About FatOldClimber

Patient story, 20.7K subscribers. 10 of their videos are in GLP-1 TV, 439K views between them, mostly on Mounjaro, Wegovy.

Every FatOldClimber video

Read next

Our guides closest to what this video covers, with prices checked weekly.

  • Mounjaro for weight loss, and why Zepbound exists

    Mounjaro is tirzepatide approved for type 2 diabetes. Zepbound is the same molecule from the same maker, approved for weight management, and it goes to the same 15 mg. So unlike Ozempic and Wegovy, there is no dose ceiling pushing you from one to the other: the reason people move is coverage and cash price, not strength. Using Mounjaro for weight is off-label and a prescriber's decision. In the one head-to-head trial, tirzepatide beat semaglutide, 20.2% mean body-weight loss at 72 weeks against 13.7%.

  • Mounjaro vs Ozempic, and the trial everyone quotes about it

    Mounjaro is tirzepatide and Ozempic is semaglutide: different molecules, not two brands of the same drug. Both are approved for type 2 diabetes, and the weight-loss versions are Zepbound and Wegovy. In the one head-to-head trial, SURMOUNT-5, tirzepatide produced 20.2% mean body-weight loss at 72 weeks against semaglutide's 13.7%. The detail almost every page omits: that trial dosed semaglutide to 2.4 mg in people without diabetes, which is the Wegovy range. Ozempic tops out at 2 mg. The famous result did not test Ozempic's dose range.

  • Mounjaro side effects: the label's numbers by dose, the low blood sugar risk, and how tirzepatide compares at weight-loss doses

    On Mounjaro's own label, the common side effects are stomach ones and they rise with the dose: nausea in 12, 15 and 18 percent of people at 5, 10 and 15 mg against 4 percent on placebo, diarrhea 12 to 17 against 9, and any gastrointestinal reaction in 37 to 44 percent against 20. Most of it happens while the dose is being raised and fades. Low blood sugar is rare on Mounjaro alone and is mainly a risk when it is added to insulin or a sulfonylurea. Below: the full table, the rare warnings, and why Zepbound's numbers for the same molecule look higher.

Find more like it

Side effectsDose changeWeigh-in and resultsFood, protein and eatingFood noise and cravingsInjection techniqueStopping and maintenanceHow it works

Up next

More from this collection

Watched it? See what it costs.

Every GLP-1 program we track, ranked by what actually leaves your account.

Back to GLP-1 TV